ASTRAZENECA PLC DL-,25/ GB0009895292 /
2024-05-23 9:00:31 PM | Chg. -0.400 | Volume | Bid9:21:43 PM | Ask9:21:43 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
145.750EUR | -0.27% | 3,517 Turnover: 512,659.900 |
145.850Bid Size: 40 | 146.200Ask Size: 40 | 226.35 bill.EUR | - | - |
GlobeNewswire
2:00 PM
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
GlobeNewswire
05-08
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
05-06
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire
05-02
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...